Article: article from journal or magazin.
Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines.
Thirty monoclonal antibodies from eight laboratories exchanged after the First Workshop on Monoclonal Antibodies to Human Melanoma held in March 1981 at NIH were tested in an antibody-binding radioimmunoassay using a panel of 28 different cell lines. This panel included 12 melanomas, three neuroblastomas, four gliomas, one retinoblastoma, four colon carcinomas, one lung carcinoma, one cervical carcinoma, one endometrial carcinoma, and one breast carcinoma. The reactivity pattern of the 30 monoclonal antibodies tested showed that none of them were directed against antigens strictly restricted to melanoma, but that several of them recognize antigenic structures preferentially expressed on melanoma cells. A large number of antibodies were found to crossreact with gliomas and neuroblastomas. Thus, they seem to recognize neuroectoderm associated differentiation antigens. Four monoclonal antibodies produced in our laboratory were further studied for the immunohistological localization of melanoma associated antigens on fresh tumor material. In a three-layer biotin-avidin-peroxidase system each antibody showed a different staining pattern with the tumor cells, suggesting that they were directed against different antigens.
Antibodies, Monoclonal/immunology, Antibodies, Neoplasm/immunology, Antibody Specificity, Antigens, Neoplasm, Antigens, Surface/analysis, Breast Neoplasms/immunology, Cell Line, Colonic Neoplasms/immunology, Cross Reactions, Epitopes/immunology, Female, Histocompatibility Antigens Class II/immunology, Humans, Immunoenzyme Techniques, Lung Neoplasms/immunology, Melanoma/immunology, Melanoma-Specific Antigens, Neoplasm Proteins/analysis, Neoplasm Proteins/immunology, Neoplasms, Nerve Tissue/immunology, Radioimmunoassay, Uterine Cervical Neoplasms/immunology, Uterine Neoplasms/immunology
Web of science
Last modification date